[Wiley Current Protocols webinar]: Strategies for Bioprinting Perfusable & Heterogeneous 3D Tissue Models

Wiley Current Protocols hosted Aspect's Application Scientists, Erin Bedford and Kyle Grode to discuss 3D bioprinting strategies. 

In this webinar, Erin & Kyle explain how Aspect's microfluidic 3D bioprinting technology can be used to:

  • Bioprint hollow core & perfusable fibres
  • Pattern materials to provide support for soft tissue constructs
  • Bioprint cell-laden biomaterial layers and interfaces to create 3D tissue models, such as a kidney disease model

 

Erin0063_square

Dr. Erin Bedford

Head of the Discovery Ecosystem & Product Manager

As Head of the Discovery Ecosystem & Product Manager at Aspect Biosystems, Erin oversees the technical and application support for researchers using our RX1 bioprinting platform. Erin received her PhD in nanotechnology engineering from the University of Waterloo and the Pierre and Marie Curie University (UPMC) in Paris.

Kyle headshot

Dr. Kyle Grode

Applications Scientist

As a member of the Applications Scientist team at Aspect Biosystems, Kyle provides application support to researchers using our RX1™ bioprinter. Kyle received his PhD in cell biology from the University of North Carolina at Chapel Hill.

Missed our past webinars? You can access them on-demand here.